Publikationen von S. Modell

Wegerer, M.; Adena, S.; Pfennig, A.; Czamara, D.; Sailer, U.; Bettecken, T.; Mueller-Myhsok, B.; Modell, S.; Ising, M.: Variants within the GABA transaminase (ABAT) gene region are associated with somatosensory evoked EEG potentials in families at high risk for affective disorders. PSYCHOLOGICAL MEDICINE 43 (6), S. 1207 - 1217 (2013)

Horstmann, S.; Ising, M.; Adena, S.; Pfenning, A.; Modell, S.; Bettecken, T.; Müller-Myhsole, B.; Holsboer, F.; Binder, E. B.: Fine-Mapping of Genetic Loci Linked to REM-Density in the Munich Vulnerability Study. Biological Psychiatry 67 (9 Suppl.1), S. 128S - 128S (2010)

Wegerer, M.; Adena, S.; Binder, E. B.; Huber, J.; Sailer, U.; Bettecken, T.; Müller-Myhsok, B.; Modell, S.; Holsboer, F.; Ising, M.: Polymorphisms within the 4-aminobutyrate aminotransferase gene are associated with long-latency somatosensory potentials in families vulnerable for affective disorders. Pharmacopsychiatry 42 (5), S. 246 - 246 (2009)

Friess, E.; Schmid, D.; Modell, S.; Brunner, H.; Lauer, C. J.; Holsboer, F.; Ising, M.: Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders. Journal of Psychiatric Research 42 (14), S. 1154 - 1162 (2008)

Ströhle, A.; Scheel, M.; Modell, S.; Holsboer, F.: Blunted ACTH response to dexamethasone suppression-CRH stimulation in posttraumatic stress disorder. Journal of Psychiatric Research 42 (14), S. 1185 - 1188 (2008)

Friess, E.; Modell, S.; Brunner, H.; Tagaya, H.; Lauer, C. J.; Holsboer, F.; Ising, M.: The Munich vulnerability study on affective disorders: microstructure of sleep in high-risk subjects. European Archives of Psychiatry and Clinical Neuroscience 258 (5), S. 285 - 291 (2008)

Ising, M.; Silja, A.; Lucae, S.; Siebertz, A.; Depping, A. M.; Modell, S.; Müller-Myhsok, B.; Holsboer, F.: Molecular genetics of individual differences: What can we learn for related disorders? International Journal of Psychology 43 (3-4), S. 195 - 195 (2008)

Ising, M.; Adena, S.; Binder, E.; Pfennig, A.; Schalling, M.; Mueller-Myhsok, B.; Modell, S.; Holsboer, F.: Genetic determinants of neurobiological vulnerability markers in depression. European Psychiatry 23 (Suppl. 2), S. S9 - S9 (2008)

Modell, S.; Ising, M.; Holsboer, F.; Lauer, C. J.: Regarding "The Munich Vulnerability-Study on Affective Disorders: Premorbid Polysomnographic Profile of Affected High-Risk Probands" Reply. Biological Psychiatry 62, S. 702 - 704 (2007)

van Rossum, E. F. C.; Binder, E. B.; Majer, M.; Koper, J. W.; Ising, M.; Modell, S.; Salyakina, D.; Lamberts, S. W. J.; Holsboer, F.: Polymorphisms of the glucocorticoid receptor gene and major depression. Biological Psychiatry 59 (8), S. 681 - 688 (2006)

Baghai, T. C.; Binder, E. B.; Schule, C.; Salyakina, D.; Eser, D.; Lucae, S.; Zwanzger, P.; Haberger, C.; Zill, P.; Ising, M. et al.; Deiml, T.; Uhr, M.; Illig, T.; Wichmann, H.-E.; Modell, S.; Nothdurfter, C.; Holsboer, F.; Müller-Myhsok, B.; Möller, H.-J.; Rupprecht, R.; Bondy, B.: Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Molecular Psychiatry 11, S. 1003 - 1015 (2006)

Friess, E.; Kümpfel, T.; Modell, S.; Winkelmann, J.; Holsboer, F.; Ising, M.; Trenkwalder, C.: Paroxetine treatment improves motor symptoms in patients with multiple system atrophy. Parkinsonism & Related Disorders 12 (7), S. 432 - 437 (2006)

Modell, S.; Ising, M.; Holsboer, F.; Lauer, C. J.: The Munich vulnerability study on affective disorders: Premorbid polysomnographic profile of affected high-risk probands. Biological Psychiatry 58 (9), S. 694 - 699 (2005)

Ising, M.; Binder, E. B.; Dose, T.; Horstmann, S.; Kern, N.; Kloiber, S.; Künzel, H. E.; Lucae, S.; Pfennig, A.; Unschuld, P. G. et al.; Modell, S.; Holsboer, F.: Change in HPA system function predicts treatment response in depression. Pharmacopsychiatry 38 (5), S. 251 - 251 (2005)

Ising, M.; Künzel, H. E.; Binder, E. B.; Nickel, T.; Modell, S.; Holsboer, F.: The combined dexamethasone/CRH test as a potential surrogate marker in depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 29 (6), S. 1085 - 1093 (2005)

Ising, M.; Lauer, C. J.; Holsboer, F.; Modell, S.: The Munich vulnerability study on affective disorders: premorbid neuroendocrine profile of affected high-risk probands. Journal of Psychiatric Research 39 (1), S. 21 - 28 (2005)

Lauer, C. J.; Modell, S.; Schreiber, W.; Krieg, J. C.; Holsboer, F.: Prediction of the development of a first major depressive episode with a rapid eye movement sleep induction test using the cholinergic agonist RS 86. Journal of Clinical Psychopharmacology 24 (3), S. 356 - 357 (2004)

Ising, M.; Dietl, T.; Dirlich, G.; Vogl, L.; Pollmächer, T.; Nickel, T.; Sonntag, A.; Strian, F.; Lechner, C.; Lauer, C. J. et al.; Modell, S.: Long-latency somatosensory potentials in high risk probands for affective disorders. Journal of Psychiatric Research 38 (2), S. 219 - 221 (2004)

Binder, E. B.; Salyakina, D.; Lichtner, P.; Wochnik, G. M.; Ising, M.; Pütz, B.; Papiol, S.; Seaman, S.; Lucae, S.; Kohli, M. et al.; Nickel, T.; Künzel, H.; Fuchs, B.; Majer, M.; Pfennig, A.; Kern, N.; Brunner, J.; Modell, S.; Baghai, T.; Deiml, T.; Zill, P.; Bondy, B.; Rupprecht, R.; Messer, T.; Köhnlein, O.; Dabitz, H.; Brückl, T.; Müller, N.; Pfister, H.; Lieb, R.; Mueller, J. C.; Löhmussaar, E.; Strom, T. M.; Bettecken, T.; Meitinger, T.; Uhr, M.; Rein, T.; Holsboer, F.; Müller-Myhsok, B.: Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature Genetics 36, S. 1319 - 1325 (2004)

Ising, M.; Lauer, C. J.; Holsboer, F.; Modell, S.: The Munich vulnerability study on affective disorders: premorbid psychometric profile of affected individuals. Acta Psychiatrica Scandinavica 109, S. 332 - 338 (2004)